Prescription and pharmacy process

Getting a medicinal cannabis prescription in New Zealand is not like getting antibiotics. It is a regulated pharmaceutical pathway, not a general licence to use cannabis. Under the Misuse of Drugs Act 1975 and the Medicinal Cannabis Scheme administered by the Ministry of Health, access flows through a medical practitioner and a licensed pharmacy. The scheme legalises the prescribing and dispensing of manufactured medicinal cannabis preparations that meet Good Manufacturing Practice (GMP) standards, and the Ministry approves each one before it can be supplied. The most common mistake newcomers make is assuming “legal medicinal cannabis” means they can smoke raw plant material or buy unregulated goods. The legal item is a manufactured pharmaceutical; even raw flower, when available, is prescribed and dispensed through a pharmacy, not a dispensary.

The one decision rule

If you are a patient, the single most useful rule is: the prescription is the only legal doorway, and the pharmacy is the only legal counter. You cannot buy medicinal cannabis from a clinic, a website, or a dispensary. A New Zealand-registered medical practitioner writes the prescription; a licensed pharmacy dispenses it. Every other route is outside the Medicinal Cannabis Scheme and is not protected by the Misuse of Drugs Act.

What the prescription process actually looks like

The prescription process runs through the standard healthcare system. You do not apply to the government for cannabis. You see a doctor who is legally able to prescribe under the Misuse of Drugs Act 1975 and the Medicinal Cannabis Scheme. The doctor assesses whether medicinal cannabis is appropriate for your condition, and if so, writes a prescription. That prescription is then dispensed by a licensed pharmacy. The whole pathway is regulated by the Medicinal Cannabis Agency, which sits within Medsafe and the New Zealand Ministry of Health.

The most common misconception is that “legal medicinal cannabis” means you can smoke raw plant material bought from a dispensary. In this country, the legal preparation is a manufactured pharmaceutical that meets GMP standards and has been notified to the Ministry under the Misuse of Drugs Act. Raw flower is available, but only as a prescribed, pharmacy-dispensed item. The Medicinal Cannabis Scheme (MCS), established under the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018, legalised this pathway. Since 1 April 2020, when the scheme’s regulations came into force, preparations must meet GMP standards and be approved by the Ministry to be legally supplied.

A patient cannot walk into a pharmacy and buy cannabis items. The process starts with a prescription from a medical practitioner, and the prescription is dispensed through a licensed pharmacy. Even when flower is prescribed, it is dispensed as a pharmaceutical through a pharmacy, not a recreational dispensary.

The prescribing steps

1. You discuss your condition with a medical practitioner (GP, specialist, or nurse practitioner).
2. The practitioner decides whether medicinal cannabis is appropriate for your situation, based on clinical judgement and the NZ Formulary guidance.
3. If prescribed, the practitioner writes a prescription for a specific preparation (e.g., a flower strain or an oil) with a dose and administration route.
4. The prescription is dispensed at a licensed pharmacy, not a dispensary or retail store.
5. The pharmacy orders the item from a licensed importer or local manufacturer, then dispenses it to you.

The Ministry’s Medicinal Cannabis Agency (MCA) manages the scheme: it issues licences to import, manufacture and supply, and it maintains a public register of approved preparations. As of 2023, the MCA had approved over 60 items, including flower and oils, from brands such as Tilray, Medleaf, NUBU, Aurora, Cann Group, Spectrum, LGP, Helius, MedReleaf, Bedrocan, Cannabisol and Eve. (Medicinal Cannabis Agency, 2023)

The key legal point: under the Misuse of Drugs Act 1975 and the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, a prescription is required; there is no general “medical cannabis licence” for patients. A doctor must decide if medicinal cannabis is appropriate and issue a prescription under Section 25 of the Act. The prescription is then dispensed by a licensed pharmacy. The raw flower is a controlled drug and must be prescribed and dispensed through the normal pharmacy chain; it cannot be sold over the counter or in a coffee shop.

Doctors can prescribe under the Medicinal Cannabis Scheme, which began in 2020. Preparations must meet GMP standards and be approved by the Ministry; the scheme allows any doctor to prescribe, but most prefer to refer to a specialist cannabis clinic.

What the first consultation covers

The first consultation is usually with a GP or a specialist cannabis clinic. A doctor will review the patient’s medical history, current medications, and the condition being treated. The doctor may ask about previous cannabis use, but this does not guarantee a prescription. The consultation typically lasts 20-40 minutes and should cover:

• The condition and why conventional treatments have not worked
• Potential drug interactions with current medications
• The patient’s goals (e.g., pain relief, sleep, anxiety)
• The risk of side effects, including psychoactive effects, sedation, and dependence
• The cost, because medicinal cannabis is not publicly funded and prices vary

The doctor’s role

The doctor’s role is to assess eligibility, discuss risks and benefits, and prescribe if clinically appropriate. The doctor must:

• Check for contraindications (e.g., unstable heart disease, severe liver disease, current psychosis, or pregnancy/breastfeeding)
• Review current medications for interactions (especially CYP450 enzyme interactions with warfarin, clobazam, and some antidepressants)
• Confirm that conventional treatments have been tried or are unsuitable
• Choose a preparation and starting dose based on the condition, with the patient as an active partner in titration
• Provide a prescription for a specific item, not a general “cannabis” prescription
• Write the prescription for a named patient, specifying the preparation, form, and quantity

In New Zealand, only a medical practitioner can prescribe medicinal cannabis under the Misuse of Drugs Act 1975, and the prescription must meet the requirements of the Misuse of Drugs Regulations 1977.

What it costs

The cost of medicinal cannabis varies widely. A typical consultation with a specialist cannabis clinic costs approximately NZabout $150, $350, and ongoing prescriptions are about NZ$50, about $150 per follow-up. Preparation costs range from roughly NZabout $150, $400 per month for oils and about NZ$200, $500 for flower, depending on dose and the item prescribed. These are approximate 2025 market figures from the Medicinal Cannabis Agency and clinic websites; actual costs depend on the prescriber, pharmacy, and preparation. Pharmacies may add a dispensing fee of NZabout $5, about $15 per item. There is no government subsidy for medicinal cannabis; patients pay full cost unless they have private insurance that covers it (rare). Some clinics offer “cannabis care plans” with monthly fees ranging from NZ$50 to NZabout $150, but these are not regulated and vary widely.

What the Medicinal Cannabis Scheme actually allows

The Medicinal Cannabis Scheme is part of the Misuse of Drugs Act. It is not a general licence to use cannabis. Under the scheme, a medical practitioner can prescribe a manufactured cannabis preparation, and that preparation must meet GMP standards and be approved by the Ministry. The key phrase is “manufactured pharmaceutical.”

What this means in practice:

• The legal item is a pharmaceutical-grade medicine, not raw plant material you can smoke freely. Even dried flower for inhalation is a prescribed medicine, dispensed through a pharmacy.
• The scheme does not legalise possession for personal use. Possession without a prescription remains an offence under the Misuse of Drugs Act.
• Preparations must be GMP-certified and approved by the Ministry. Unregulated “street” cannabis or imported CBD oils sold online are not part of the scheme.

The scheme, established under the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 and operational from 1 April 2020, is administered by the Medicinal Cannabis Agency within Medsafe. It sets product standards, licensing for cultivation and manufacture, and a legal pathway for prescribing. (Ministry of Health, 2020)

The legal frame

Medicinal cannabis is a regulated pharmaceutical pathway under the Misuse of Drugs Act 1975, not a general licence to use cannabis. The Medicinal Cannabis Scheme, administered by the Medicinal Cannabis Agency (part of Medsafe), legalises access via a prescription from a medical practitioner. Preparations must meet GMP standards and be approved by the Ministry.

The key legal boundary: a prescription is not a permission slip to smoke raw plant material or buy unregulated items. The legal preparation is a manufactured pharmaceutical. Even when raw flower is prescribed, it is dispensed through a pharmacy as a controlled medicine, not sold over the counter. The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 set the framework; the Misuse of Drugs Act 1975 still controls the supply chain. The Medicinal Cannabis Agency licences producers, importers and pharmacies.

The Ministry of Health (2023) states that medicinal cannabis preparations must meet GMP standards and be approved before they can be prescribed. The scheme does not allow smoking raw plant material as a legal pathway; the legal preparation is a manufactured pharmaceutical.